Vilanterol - CISMeF

Preferred Label : Vilanterol;

NCIt definition : A long-acting beta-2 adrenergic agonist, with bronchodilator activity. Upon administration, vilanterol stimulates beta-2 adrenergic receptors in the lungs, thereby activating the enzyme adenylate cyclase that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP concentrations relax bronchial smooth muscle, relieve bronchospasms, and reduce inflammatory cell mediator release, especially from mast cells.;

UNII : 028LZY775B;

InChIKey : DAFYYTQWSAWIGS-DEOSSOPVSA-N;

CAS number : 503068-34-6;

Molecule name : GW 642444; GW-642444;

Détails

Origin ID

C152875;

UMLS CUI

C2935023;

Automatic exact mappings (from CISMeF team)
- Product containing vilanterol (medicinal product) [SNOMED CT concept]
Currated CISMeF NLP mapping
- 1,3-benzenedimethanol, alpha-[[[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-4-hydroxy-, (alphar)- [Substance BNPC]
- Vilanterol [SMS substance]
- Vilanterol (substance) [SNOMED CT concept]
- vilanterol [MeSH concept]
- vilanterol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing vilanterol (medicinal product) [SNOMED CT concept]
- Vilanterol (substance) [SNOMED CT concept]
- vilanterol [MeSH concept]
- vilanterol [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients